On the front tonightAstraZeneca Posts Q2 Beat, Reaffirms 2026 Outlook
Today's story
AstraZeneca Announces $1.5 Billion Pipeline Savings Plan
AstraZeneca announced a restructuring program expected to deliver about $1.5 billion in savings to support drug-development investments and its goal of $80 billion in annual revenue by 2030, after quarterly results beat expectations. The company is also considering cancer-vaccine development, though executives say rivals are better positioned in personalized vaccines for now and AstraZeneca sees challenges in scaling the technology.
Business · 8 sources · 2dRead it
The journal
Open the journal →The conversation starts in the journal — be the first to post.
About Pascal Soriot
Sir Pascal Claude Roland Soriot is a French-born Australian businessman and chief executive of the British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca.
Everything about Pascal Soriot →- Occupation
- entrepreneur, veterinarian
- Position held
- chief executive officer
- Citizenship
- France
- Born
- May 23, 1959